ArticleMolecular & cellular proteomics : MCP2022

eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors.

Maruan Hijazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.